Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Effect and Immunogenicity of Vaccine”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT04756271
What this trial is testing

Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection

Who this might be right for
Vaccine Adverse ReactionSeroconversion
Zagazig University 246
Not applicableStudy completedNCT05283902
What this trial is testing

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine-Preventable Diseases
Federal University of Espirito Santo 260
Early research (Phase 1)Study completedNCT01764126
What this trial is testing

Pneumococcal Protein Vaccine Safety and Immunogenicity Trial

Who this might be right for
Adverse Effects
International Centre for Diarrhoeal Disease Research, Bangladesh 280
Not applicableStudy completedNCT05116748
What this trial is testing

COVID19 Vaccine in SOT Adult Recipients

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Response Impaired+4 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 364
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Testing effectiveness (Phase 2)Study completedNCT04930003
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Early research (Phase 1)Study completedNCT05685953
What this trial is testing

A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine

Who this might be right for
COVID-19 Respiratory InfectionCOVID-19 Vaccine Adverse Reaction
Matti Sällberg 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078357
What this trial is testing

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Who this might be right for
Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse Reaction+3 more
University of Sao Paulo General Hospital 60
Early research (Phase 1)UnknownNCT05171946
What this trial is testing

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

Who this might be right for
SafetyVaccine ReactionVaccine Adverse Reaction+1 more
Iman Almansour 30
Early research (Phase 1)UnknownNCT03739229
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine

Who this might be right for
Vaccine Adverse Reaction
Research Institute of Influenza, Russia 40
Not applicableUnknownNCT05483725
What this trial is testing

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Who this might be right for
Kidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more
Institute for Clinical and Experimental Medicine 108
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Not applicableUnknownNCT05258708
What this trial is testing

COVID-19 Vaccine Reactogenicity and Immunogenicity

Who this might be right for
COVID-19Vaccine Immune ResponseVaccine Adverse Reaction
Korea University Guro Hospital 179
Testing effectiveness (Phase 2)Study completedNCT01512706
What this trial is testing

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Who this might be right for
The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants
Institute of Medical Biology, Chinese Academy of Medical Sciences 660
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Large-scale testing (Phase 3)Study completedNCT06078423
What this trial is testing

A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)

Who this might be right for
Rabies Vaccine Adverse Reaction
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,880
Testing effectiveness (Phase 2)Study completedNCT04949490
What this trial is testing

A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

Who this might be right for
COVID-19SARS-CoV-2 Infection
BioNTech SE 137
Post-approval studies (Phase 4)Study completedNCT05898464
What this trial is testing

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Who this might be right for
Vaccination; InfectionVaccine Adverse Reaction
Seoul National University Hospital 71
Early research (Phase 1)Study completedNCT06032000
What this trial is testing

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Who this might be right for
COVID-19 InfectionCOVID-19 Vaccine Adverse Reaction
Lemonex 20
Not applicableUnknownNCT04832932
What this trial is testing

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Who this might be right for
COVID-19 Vaccines
Mebo Research, Inc. 2,000
Load More Results